Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 12 (2), 187-97

Drug Treatment of Obsessive-Compulsive Disorder

Affiliations
Review

Drug Treatment of Obsessive-Compulsive Disorder

Michael Kellner. Dialogues Clin Neurosci.

Abstract

Knowledge of pharmacotherapeutic treatment options in obsessive-compulsive disorder (OCD) has grown considerably over the past 40 years. Serotonergic antidepressants, such as selective serotonin reuptake inhibitors (SSRls) and clomipramine, are the established pharmacologic first-line treatment of OCD. Medium to large dosages and acute treatment for at least 3 months are recommended until efficacy is assessed. In case of significant improvement, maintenance treatment is necessary, Unfortunately, about half of the patients do not respond sufficiently to oral serotonergic antidepressants; augmentation with atypical antipsychotics is an established second-line drug treatment strategy. Alternatives include intravenous serotonergic antidepressants and combination with or switch to cognitive behavioral psychotherapy. Remarkably, a considerable proportion of OCD patients still do not receive rational drug treatment. Novel research approaches, such as preliminary treatment studies with glutamatergic substances, and trials with further drugs, as well as needed aspects of future research, are reviewed.

Similar articles

See all similar articles

Cited by 15 PubMed Central articles

See all "Cited by" articles

References

    1. Fernandez-Cordoba E, Lopez-Ibor Alino J. La monoclorimipramina en enfermos psiquiatricos resistentes a otros tratamientos. . Acta Luso-Esp Neurol Psiquiatr Ciene Afines. 1967;26:119–147. - PubMed
    1. Van Renynghe de Voxvrie G. Anafranil (G34586) in obsessive neurosis. . Acta Neurol Psychiatr Belg. 1968;68:787–792. - PubMed
    1. Rack M, Chir D. Experience with intravenous clomipramine. . In: Obsessional States and their Treatment with Anafranil. Manchester, UK: Geigy;. 1970
    1. Thoren P, Asberg M, Cronholm B, Jornestedt L, Traskman L. Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. . Arch Gen Psychiatry. 1980;22:667–687. - PubMed
    1. Marks IM, Stern RS, Mawson D, et al. Clomipramine and exposure for obsessive-compulsive rituals: i. . Br J Psychiatry. 1980;136:1–25. - PubMed

MeSH terms

Substances

LinkOut - more resources

Feedback